The global digital therapeutics (DTx) market is anticipated to grow at a considerable CAGR of 29.0% during the forecast period (2021-2027). The growing pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. According to the World health organization (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Chronic diseases are having high levels of uncertainty and a new care lifestyle would support their behaviour. Through digital health technology, it will enhance prevention, diagnosis along with proper management of cardiovascular diseases that leads to getting better health outcomes.
Browse the full report description of "Global Digital Therapeutics (DTx) Market Research By Product Type (Software and Device), By Sales Channel (B2C and B2B) and By Application (Preventive Applications and Treatment/Care-related Applications) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/digital-therapeutics-market
The key players operating in the global digital therapeutics (DTx) market had been adopting strategies such as new launches to gain major market share. For instance, in July 2021, one of the software-enabled healthcare platform companies across the globe named Happify Health had introduced Ensemble, which is considered as first transdiagnostic prescription digital therapeutic in order to do the treatment of patients suffering from Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD).
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Product Type
o By Sales Channel
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Digital Therapeutics (DTx) Market
By Product Type
• Software
• Device
By Sales Channel
• B2C
• B2B
By Application
• Preventive Applications
• Treatment/Care-related Applications
Global Digital Therapeutics (DTx) Market by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digital-therapeutics-market